The association of smoking with urinary and sexual function recovery following radical prostatectomy for localized prostate cancer: a systematic review and meta-analysis.
Journal
Prostate cancer and prostatic diseases
ISSN: 1476-5608
Titre abrégé: Prostate Cancer Prostatic Dis
Pays: England
ID NLM: 9815755
Informations de publication
Date de publication:
27 Jul 2023
27 Jul 2023
Historique:
received:
19
05
2023
accepted:
14
07
2023
revised:
07
07
2023
medline:
28
7
2023
pubmed:
28
7
2023
entrez:
27
7
2023
Statut:
aheadofprint
Résumé
Urinary and sexual dysfunction after radical prostatectomy remains a major cause of morbidity, despite widespread availability of pharmacological and rehabilitative treatments. Smoking is a modifiable risk factor known to correlate with erectile and urinary dysfunction and we hypothesise that smoking cessation may improve post-prostatectomy urinary and sexual function recovery. Our objective is to systematically evaluate literature describing the association of smoking status with urinary and sexual function in men following radical prostatectomy. In total, 310 unique records were identified through a systematic search of the MEDLINE, EMBASE, Scopus, Web of Science, CINAHL and CENTRAL databases up to February 2023. Nine studies reported smoking status and post radical prostatectomy urinary and sexual function outcomes in men with localized prostate cancer. Risk of bias was assessed and meta-analysis included six studies. Smokers had inferior erectile function after prostatectomy compared to non-smokers (OR 0.73, [95% CI 0.56-0.95]) during follow-up, while urinary incontinence was not statistically different between groups (OR 1.20, [95% CI 0.75-1.91]). Smoking cessation improved the EPIC-26 sexual domain score with 6.6 points on average [p = 0.03] to a clinically significant maximum of 12.5 points at 18-24 months. Smoking is associated with impaired sexual function recovery after radical prostatectomy and quitting may improve sexual function >18 months. Current evidence shows no such association for urinary outcomes. Further studies are needed to corroborate findings.
Sections du résumé
BACKGROUND
BACKGROUND
Urinary and sexual dysfunction after radical prostatectomy remains a major cause of morbidity, despite widespread availability of pharmacological and rehabilitative treatments. Smoking is a modifiable risk factor known to correlate with erectile and urinary dysfunction and we hypothesise that smoking cessation may improve post-prostatectomy urinary and sexual function recovery. Our objective is to systematically evaluate literature describing the association of smoking status with urinary and sexual function in men following radical prostatectomy.
METHODS
METHODS
In total, 310 unique records were identified through a systematic search of the MEDLINE, EMBASE, Scopus, Web of Science, CINAHL and CENTRAL databases up to February 2023. Nine studies reported smoking status and post radical prostatectomy urinary and sexual function outcomes in men with localized prostate cancer. Risk of bias was assessed and meta-analysis included six studies.
RESULTS
RESULTS
Smokers had inferior erectile function after prostatectomy compared to non-smokers (OR 0.73, [95% CI 0.56-0.95]) during follow-up, while urinary incontinence was not statistically different between groups (OR 1.20, [95% CI 0.75-1.91]). Smoking cessation improved the EPIC-26 sexual domain score with 6.6 points on average [p = 0.03] to a clinically significant maximum of 12.5 points at 18-24 months.
CONCLUSIONS
CONCLUSIONS
Smoking is associated with impaired sexual function recovery after radical prostatectomy and quitting may improve sexual function >18 months. Current evidence shows no such association for urinary outcomes. Further studies are needed to corroborate findings.
Identifiants
pubmed: 37500786
doi: 10.1038/s41391-023-00701-2
pii: 10.1038/s41391-023-00701-2
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Nature Limited.
Références
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.
pubmed: 33538338
doi: 10.3322/caac.21660
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7–33.
pubmed: 35020204
doi: 10.3322/caac.21708
Litwin MS, Melmed GY, Nakazon T. Life after radical prostatectomy: a longitudinal study. J Urol. 2001;166:587–92.
pubmed: 11458073
doi: 10.1016/S0022-5347(05)65989-7
Stanford JL, Feng Z, Hamilton AS, Gilliland FD, Stephenson RA, Eley JW, et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. Jama 2000;283:354–60.
pubmed: 10647798
doi: 10.1001/jama.283.3.354
Lubeck DP, Litwin MS, Henning JM, Stoddard ML, Flanders SC, Carroll PR. Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE. Urology. 1999;53:180–6.
pubmed: 9886609
doi: 10.1016/S0090-4295(98)00408-7
Litwin MS, Flanders SC, Pasta DJ, Stoddard ML, Lubeck DP, Henning JM. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology. 1999;54:503–8.
pubmed: 10475362
doi: 10.1016/S0090-4295(99)00172-7
Haglind E, Carlsson S, Stranne J, Wallerstedt A, Wilderäng U, Thorsteinsdottir T, et al. Urinary incontinence and erectile dysfunction after robotic versus open radical prostatectomy: a prospective, controlled, nonrandomised trial. Eur Urol. 2015;68:216–25.
pubmed: 25770484
doi: 10.1016/j.eururo.2015.02.029
Resnick MJ, Koyama T, Fan KH, Albertsen PC, Goodman M, Hamilton AS, et al. Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med. 2013;368:436–45.
pubmed: 23363497
pmcid: 3742365
doi: 10.1056/NEJMoa1209978
Tal R, Alphs HH, Krebs P, Nelson CJ, Mulhall JP. Erectile function recovery rate after radical prostatectomy: a meta-analysis. J Sex Med. 2009;6:2538–46.
pubmed: 19515209
pmcid: 4097184
doi: 10.1111/j.1743-6109.2009.01351.x
Smith DS, Carvalhal GF, Schneider K, Krygiel J, Yan Y, Catalona WJ. Quality-of-life outcomes for men with prostate carcinoma detected by screening. Cancer 2000;88:1454–63.
pubmed: 10717630
doi: 10.1002/(SICI)1097-0142(20000315)88:6<1454::AID-CNCR25>3.0.CO;2-S
Smith DP, King MT, Egger S, Berry MP, Stricker PD, Cozzi P, et al. Quality of life three years after diagnosis of localised prostate cancer: population based cohort study. BMJ. 2009;339:b4817.
pubmed: 19945997
pmcid: 2784818
doi: 10.1136/bmj.b4817
Papa N, O'Callaghan M, James E, Millar J. Prostate Cancer in Australian and New Zealand Men: Patterns of care withing PCOR-ANZ 2015-2018. Melbourne, Vic: Monash University & Movember; 2021.
Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358:1250–61.
pubmed: 18354103
doi: 10.1056/NEJMoa074311
Meyer JP, Gillatt DA, Lockyer R, Macdonagh R. The effect of erectile dysfunction on the quality of life of men after radical prostatectomy. BJU Int. 2003;92:929–31.
pubmed: 14632849
doi: 10.1111/j.1464-410X.2003.04530.x
EAU – ESTRO – ESUR – SIOG Guidelines on Prostate Cancer. [Internet]. No date [cited 03-07-2021]. Available from: https://uroweb.org/guideline/prostate-cancer/ .
Koskimäki J, Hakama M, Huhtala H, Tammela TL. Association of smoking with lower urinary tract symptoms. J Urol. 1998;159:1580–2.
pubmed: 9554358
doi: 10.1097/00005392-199805000-00046
Schauer I, Keller E, Müller A, Madersbacher S. Have rates of erectile dysfunction improved within the past 17 years after radical prostatectomy? A systematic analysis of the control arms of prospective randomized trials on penile rehabilitation. Andrology. 2015;3:661–5.
pubmed: 26198796
doi: 10.1111/andr.12060
Ficarra V, Novara G, Artibani W, Cestari A, Galfano A, Graefen M, et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol. 2009;55:1037–63.
pubmed: 19185977
doi: 10.1016/j.eururo.2009.01.036
Campodonico F, Manuputty EE, Campora S, Puntoni M, Maffezzini M. Age is predictive of immediate postoperative urinary continence after radical retropubic prostatectomy. Urol Int. 2014;92:276–81.
pubmed: 24157865
doi: 10.1159/000353414
Lu C-H, Wu C-H, Chen Y-C, Chen C-H, Wu R, Lee Y-H, et al. Can robot-assisted radical prostatectomy improve functional outcomes compared to laparoscopic radical prostatectomy? Experience at a laparoscopic center. Urological Sci. 2019;30:124–30.
doi: 10.4103/UROS.UROS_134_18
De Carlo F, Celestino F, Verri C, Masedu F, Liberati E, Di Stasi SM. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: surgical, oncological, and functional outcomes: a systematic review. Urol Int. 2014;93:373–83.
pubmed: 25277444
doi: 10.1159/000366008
McCullough AR. Prevention and management of erectile dysfunction following radical prostatectomy. Urol Clin North Am. 2001;28:613–27.
pubmed: 11590817
doi: 10.1016/S0094-0143(05)70166-X
Basiri A, de la Rosette JJ, Tabatabaei S, Woo HH, Laguna MP, Shemshaki H. Comparison of retropubic, laparoscopic and robotic radical prostatectomy: who is the winner? World J Urol. 2018;36:609–21.
pubmed: 29362896
doi: 10.1007/s00345-018-2174-1
Pinkhasov RM, Lee T, Huang R, Berkley B, Pinkhasov AM, Dodge N, et al. Prediction of Incontinence after Robot-Assisted Radical Prostatectomy: Development and Validation of a 24-Month Incontinence Nomogram. Cancers. 2022;14:1644.
pubmed: 35406416
pmcid: 8997126
doi: 10.3390/cancers14071644
Agochukwu-Mmonu N, Murali A, Wittmann D, Denton B, Dunn RL, Montie J, et al. Development and validation of dynamic multivariate prediction models of sexual function recovery in patients with prostate cancer undergoing radical prostatectomy: results from the music statewide collaborative. Eur Urol Open Sci. 2022;40:1–8.
pubmed: 35638089
pmcid: 9142747
doi: 10.1016/j.euros.2022.03.009
O'Callaghan ME, Raymond E, Campbell J, Vincent AD, Beckmann K, Roder D, et al. Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity. Prostate Cancer Prostatic Dis. 2017;20:378–88.
pubmed: 28585573
doi: 10.1038/pcan.2017.28
Lin D, O'Callaghan M, David R, Fuller A, Wells R, Sutherland P, et al. Does urethral length affect continence outcomes following robot assisted laparoscopic radical prostatectomy (RALP)? BMC Urol. 2020;20:8.
pubmed: 32005113
pmcid: 6995073
doi: 10.1186/s12894-020-0578-x
Brookman-May SD, Campi R, Henríquez JDS, Klatte T, Langenhuijsen JF, Brausi M, et al. Latest evidence on the impact of smoking, sports, and sexual activity as modifiable lifestyle risk factors for prostate cancer incidence, recurrence, and progression: a systematic review of the literature by the European Association of Urology Section of Oncological Urology (ESOU). Eur Urol Focus. 2019;5:756–87.
pubmed: 29576530
doi: 10.1016/j.euf.2018.02.007
Allen MS, Walter EE. Health-related lifestyle factors and sexual dysfunction: a meta-analysis of population-based research. J Sex Med. 2018;15:458–75.
pubmed: 29523476
doi: 10.1016/j.jsxm.2018.02.008
Gades NM, Nehra A, Jacobson DJ, McGree ME, Girman CJ, Rhodes T, et al. Association between smoking and erectile dysfunction: a population-based study. Am J Epidemiol. 2005;161:346–51.
pubmed: 15692078
doi: 10.1093/aje/kwi052
Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB. A prospective study of risk factors for erectile dysfunction. J Urol. 2006;176:217–21.
pubmed: 16753404
doi: 10.1016/S0022-5347(06)00589-1
Watson RA, Sadeghi-Nejad H. Tobacco abuse and the urologist: time for a more proactive role. Urology. 2011;78:1219–23.
pubmed: 22137690
doi: 10.1016/j.urology.2011.08.028
Tengs TO, Osgood ND. The link between smoking and impotence: two decades of evidence. Prev Med. 2001;32:447–52.
pubmed: 11394947
doi: 10.1006/pmed.2001.0830
Haidinger G, Temml C, Schatzl G, Brössner C, Roehlich M, Schmidbauer CP, et al. Risk factors for lower urinary tract symptoms in elderly men. For the Prostate Study Group of the Austrian Society of Urology. Eur Urol. 2000;37:413–20.
pubmed: 10765071
doi: 10.1159/000020162
Rohrmann S, Crespo CJ, Weber JR, Smit E, Giovannucci E, Platz EA. Association of cigarette smoking, alcohol consumption and physical activity with lower urinary tract symptoms in older American men: findings from the third National Health And Nutrition Examination Survey. BJU Int. 2005;96:77–82.
pubmed: 15963125
doi: 10.1111/j.1464-410X.2005.05571.x
John G. Urinary incontinence and cardiovascular disease: a narrative review. Int Urogynecol J. 2020;31:857–63.
pubmed: 31350566
doi: 10.1007/s00192-019-04058-w
Teloken PE, Nelson CJ, Karellas M, Stasi J, Eastham J, Scardino PT, et al. Defining the impact of vascular risk factors on erectile function recovery after radical prostatectomy. BJU Int. 2013;111:653–7.
pubmed: 22758405
doi: 10.1111/j.1464-410X.2012.11321.x
Ku J, Krahn M, Trachtenberg J, Nesbitt M, Kalnin R, Lockwood G, et al. Changes in health utilities and health-related quality of life over 12 months following radical prostatectomy. Can Urol Assoc J 2009;3:445–52.
pubmed: 20019969
pmcid: 2792418
doi: 10.5489/cuaj.1171
Sood A, Schmid M, Campbell L, Kapoor V, Abdollah F, Klett DE, et al. Impact of smoking on perioperative outcomes after major urologic surgery. J Urol. 2015;193:e105.
doi: 10.1016/j.juro.2015.02.368
Bjurlin MA, Cohn MR, Kim DY, Freeman VL, Lombardo L, Hurley SD, et al. Brief smoking cessation intervention: a prospective trial in the urology setting. J Urol. 2013;189:1843–9.
pubmed: 23159586
doi: 10.1016/j.juro.2012.11.075
Sosnowski R, Bjurlin MA, Verze P, De Nunzio C, Shariat SF, Brausi M, et al. Role of cigarette smoking in urological malignancies and clinical interventions for smoking cessation. Cent Eur J Urol. 2016;69:366–9.
Eastham JA, Auffenberg GB, Barocas DA, Chou R, Crispino T, Davis JW, et al. Clinically localized prostate cancer: AUA/ASTRO guideline, part i: introduction, risk assessment, staging, and risk-based management. J Urol. 2022;208:10–8.
pubmed: 35536144
doi: 10.1097/JU.0000000000002757
Affentranger A, Matulewicz RS, Fankhauser CD Why and how smoking cessation must be implemented in urology clinics as a standard of care. Eur Urol. 2022;82:245–6.
pubmed: 35525775
doi: 10.1016/j.eururo.2022.04.015
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
pubmed: 33782057
pmcid: 8005924
doi: 10.1136/bmj.n71
Booth A, Clarke M, Ghersi D, Moher D, Petticrew M, Stewart L. An international registry of systematic-review protocols. Lancet. 2011;377:108–9.
pubmed: 20630580
doi: 10.1016/S0140-6736(10)60903-8
The association between smoking and urinary and sexual function following radical prostatectomy for localized prostate cancer, a systematic literature review. PROSPERO 2022 CRD42022337108 [Internet]. Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022337108 .
Thompson M, Tiwari A, Fu R, Moe E, Buckley DI. AHRQ Methods for Effective Health Care. A Framework To Facilitate the Use of Systematic Reviews and Meta-Analyses in the Design of Primary Research Studies. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012.
Covidence systematic review software. Melbourne, Australia: Veritas Health Innovation.
Katz MH. Multivariable analysis: a practice guide for clinicians. New York, NY: Cambridge University Press; 1999.
Review Manager (RevMan). Version 5.4.1. The Cochrane Collaboration. 2020.
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–12.
pubmed: 10789670
doi: 10.1001/jama.283.15.2008
Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses2021 [cited 2022 12 Oct]. Available from: https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp .
Wolff RF, Moons KGM, Riley RD, Whiting PF, Westwood M, Collins GS, et al. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med. 2019;170:51–8.
pubmed: 30596875
doi: 10.7326/M18-1376
Safavy S, Kilday PS, Slezak JM, Abdelsayed GA, Harrison TN, Jacobsen SJ, et al. Effect of a smoking cessation program on sexual function recovery following robotic prostatectomy at kaiser permanente Southern California. Perm J. 2017;21:16–138.
pubmed: 28488986
pmcid: 5424596
doi: 10.7812/TPP/16-138
Marien T, Sankin A, Lepor H. Factors predicting preservation of erectile function in men undergoing open radical retropubic prostatectomy. J Urol. 2009;181:1817–22.
pubmed: 19233413
doi: 10.1016/j.juro.2008.11.105
Anderson CB, Kaufman MR, Dietrich MS, Barocas DA, Chang SS, Cookson MS, et al. Recovery of urinary function after radical prostatectomy: identification of trajectory cluster groups. J Urol. 2012;187:1346–51.
pubmed: 22341278
doi: 10.1016/j.juro.2011.11.094
Rajih E, Meskawi M, Alenizi AM, Zorn KC, Alnazari M, Zanaty M, et al. Perioperative predictors for post-prostatectomy urinary incontinence in prostate cancer patients following robotic-assisted radical prostatectomy: Long-term results of a Canadian prospective cohort. Can Urol Assoc J 2019;13:E125–e31.
pubmed: 30332593
Salter CA, Tin AL, Bernie HL, Nascimento B, Katz DJ, Benfante NE, et al. Predictors of worsening erectile function in men with functional erections early after radical prostatectomy. J Sex Med. 2022;19:1790–6.
pubmed: 36192298
doi: 10.1016/j.jsxm.2022.08.193
Haskins AE, Han PK, Lucas FL, Bristol I, Hansen M. Development of clinical models for predicting erectile function after localized prostate cancer treatment. Int J Urol. 2014;21:1227–33.
pubmed: 25056284
doi: 10.1111/iju.12566
Mao Q, Lin Y, Chen H, Bai Y, Qin J, Zheng X, et al. Preoperative risk factors for early postoperative urinary continence recovery after non-nerve-sparing radical prostatectomy in Chinese patients: a single institute retrospective analysis. Int J Clin Exp Med. 2015;8:14105–9.
pubmed: 26550377
pmcid: 4613062
Siltari A, Riikonen J, Fode M, Murtola TJ. Effects of preoperative atorvastatin treatment on erectile function after radical prostatectomy: results from a subgroup of ESTO1, a randomized, double-blind, placebo-controlled study. J Sex Med. 2019;16:1597–605.
pubmed: 31405764
doi: 10.1016/j.jsxm.2019.07.001
Wille S, Heidenreich A, von Knobloch R, Hofmann R, Engelmann U. Impact of comorbidities on post-prostatectomy incontinence. Urol Int. 2006;76:223–6.
pubmed: 16601383
doi: 10.1159/000091623
Van der Aa F, Drake MJ, Kasyan GR, Petrolekas A, Cornu JN. The artificial urinary sphincter after a quarter of a century: a critical systematic review of its use in male non-neurogenic incontinence. Eur Urol. 2013;63:681–9.
pubmed: 23219375
doi: 10.1016/j.eururo.2012.11.034
Ficarra V, Novara G, Rosen RC, Artibani W, Carroll PR, Costello A, et al. Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol. 2012;62:405–17.
pubmed: 22749852
doi: 10.1016/j.eururo.2012.05.045
Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care. 1998;36:1002–12.
pubmed: 9674618
doi: 10.1097/00005650-199807000-00007
Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822–30.
pubmed: 9187685
doi: 10.1016/S0090-4295(97)00238-0
Szymanski KM, Wei JT, Dunn RL, Sanda MG. Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors. Urology. 2010;76:1245–50.
pubmed: 20350762
doi: 10.1016/j.urology.2010.01.027
Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11:319–26.
pubmed: 10637462
doi: 10.1038/sj.ijir.3900472
Cappelleri JC, Rosen RC. The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res. 2005;17:307–19.
pubmed: 15875061
doi: 10.1038/sj.ijir.3901327
Junge B, Nagel M. [Smoking behavior in Germany]. Gesundheitswesen. 1999;61:S121–5.
pubmed: 10726409
Lampert T, Burger M. [Smoking habits in Germany—results of the German National Telephone Health Survey 2003]. Gesundheitswesen. 2004;66:511–7.
pubmed: 15372352
doi: 10.1055/s-2004-813527
Talcott JA, Clark JA, Stark PC, Mitchell SP. Long-term treatment related complications of brachytherapy for early prostate cancer: a survey of patients previously treated. J Urol. 2001;166:494–9.
pubmed: 11458054
doi: 10.1016/S0022-5347(05)65970-8
Boettcher M, Haselhuhn A, Jakse G, Brehmer B, Kirschner-Hermanns R. Overactive bladder syndrome: an underestimated long-term problem after treatment of patients with localized prostate cancer? BJU Int. 2012;109:1824–30.
pubmed: 21952039
doi: 10.1111/j.1464-410X.2011.10623.x
Rosen RC, Allen KR, Ni X, Araujo AB. Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale. Eur Urol. 2011;60:1010–6.
pubmed: 21855209
doi: 10.1016/j.eururo.2011.07.053
Skolarus TA, Dunn RL, Sanda MG, Chang P, Greenfield TK, Litwin MS, et al. Minimally important difference for the expanded prostate cancer index composite short form. Urology. 2015;85:101–5.
pubmed: 25530370
doi: 10.1016/j.urology.2014.08.044
Mons U, Müezzinler A, Gellert C, Schöttker B, Abnet CC, Bobak M, et al. Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium. BMJ. 2015;350:h1551.
pubmed: 25896935
pmcid: 4413837
doi: 10.1136/bmj.h1551
U.S. Department of Health and Human Services. Cardiovascular Diseases, Chapter 6. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta, US: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2010. 355-62.